PT1171143E - Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto - Google Patents

Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto

Info

Publication number
PT1171143E
PT1171143E PT00920831T PT00920831T PT1171143E PT 1171143 E PT1171143 E PT 1171143E PT 00920831 T PT00920831 T PT 00920831T PT 00920831 T PT00920831 T PT 00920831T PT 1171143 E PT1171143 E PT 1171143E
Authority
PT
Portugal
Prior art keywords
pharmaceutical
composition
extract
tremoch
cosmetic
Prior art date
Application number
PT00920831T
Other languages
English (en)
Inventor
Philippe Msika
Piccirilli Antoine
Paul Francois
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Publication of PT1171143E publication Critical patent/PT1171143E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
PT00920831T 1999-04-19 2000-04-18 Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto PT1171143E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904875A FR2792202B1 (fr) 1999-04-19 1999-04-19 Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait

Publications (1)

Publication Number Publication Date
PT1171143E true PT1171143E (pt) 2005-03-31

Family

ID=9544562

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00920831T PT1171143E (pt) 1999-04-19 2000-04-18 Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto

Country Status (10)

Country Link
US (2) US7029713B2 (pt)
EP (1) EP1171143B9 (pt)
JP (1) JP5329731B2 (pt)
KR (1) KR100818010B1 (pt)
AT (1) ATE279934T1 (pt)
DE (1) DE60015112T8 (pt)
ES (1) ES2228500T3 (pt)
FR (1) FR2792202B1 (pt)
PT (1) PT1171143E (pt)
WO (1) WO2000062789A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813018B1 (fr) * 2000-08-21 2004-02-06 Boots Co Plc Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique
FR2823440B1 (fr) * 2000-11-14 2004-06-04 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
FR2822068B1 (fr) * 2001-03-15 2004-12-17 Pharmascience Lab Composition topique comprenant une association de lipides furanniques d'avocat et d'isoflavones
FR2834213B1 (fr) * 2001-12-27 2004-06-04 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2834216B1 (fr) * 2001-12-27 2004-04-30 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2834638B1 (fr) * 2002-01-11 2004-04-02 Medix Lab Composition comprenant en association au moins un flavonoide, au moins un extrait peptidique de lupin et au moins une huile vegetale, son utilisation comme agent dermatologique ou dermo-cosmetique
KR100490212B1 (ko) * 2002-06-21 2005-05-17 주식회사 바이오랜드 피부 각질층의 아미노산 구성비율을 가지는 아미노산복합물과 그것을 함유한 노화방지 화장료 조성물
AU2003264192A1 (en) * 2002-08-30 2004-03-19 Biopharmacopae Design International Inc. Plant extracts for treatment of angiogenesis and metastasis
EP1405572A1 (en) * 2002-10-04 2004-04-07 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Modified lupin proteins for the preparation of water dispersible product forms of fat soluble compounds
FR2847473B1 (fr) 2002-11-25 2007-06-29 Expanscience Lab Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
WO2005073017A1 (ja) * 2004-02-02 2005-08-11 Daihatsu Motor Co., Ltd. 自動車用シート
FR2867074B1 (fr) * 2004-03-08 2009-10-30 Clarins Lab Composition cosmetique amincissante comprenant en tant qu'agent actif un inhibiteur de metalloproteinases
JP4815752B2 (ja) 2004-04-01 2011-11-16 味の素株式会社 アミノ酸含有飲食品
FR2868703B1 (fr) 2004-04-08 2008-06-13 Expanscience Sa Lab Extrait total de lupin constitue d'un extrait de sucres de lupin et d'un extrait peptidique de lupin, procede d'obtention et utilisation
FR2869541B1 (fr) 2004-04-30 2007-12-28 Expanscience Sa Lab Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
DE102004043802A1 (de) * 2004-09-08 2006-03-09 Henkel Kgaa Mund- und Zahnpflege- und reinigungsmittel mit entzündungshemmender Wirkung
FR2875134B1 (fr) 2004-09-16 2007-08-24 Oreal Utilisation cosmetique d'une composition renfermant un derive ascorbique et des particules de polyamide
FR2893628B1 (fr) 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
KR100849019B1 (ko) * 2006-06-28 2008-07-29 (주)더페이스샵코리아 화이트 루핀 추출물을 함유하는 화장료 조성물
KR101245811B1 (ko) * 2006-08-18 2013-03-20 주식회사 엘지생활건강 식물 혼합 추출물인 셀리언스를 함유하는 피부노화 예방 및개선용 화장료 조성물
US7571061B2 (en) * 2007-04-17 2009-08-04 The United States Of America As Represented By The Secretary Of Agriculture Non-destructive method of measuring a moisture content profile across a hygroexpansive, composite material
RU2010116271A (ru) * 2007-09-26 2011-11-10 Селджин Селльюлар Терапьютикс (Us) Ангиогенные клетки из плацентарного перфузата человека
FR2921836B1 (fr) * 2007-10-05 2013-01-18 Limousine D Applic Biolog Ditesilab Soc Ind Utilisation d'un principe actif combinant des principes actifs issus de medicago sativa et de lupinus albus pour lutter contre les poches sous les yeux
GB0921001D0 (en) 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
AU2011315525B2 (en) 2010-10-12 2016-05-12 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Antimicrobial protein
FR2975004B1 (fr) 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
EP2548458B1 (en) * 2011-07-22 2013-07-03 HPF Nutraceutics S.r.L. Lupin-derived compounds having hypotensive activity and process for their production
KR101491902B1 (ko) * 2012-04-06 2015-02-11 경남과학기술대학교 산학협력단 콜라게나제의 활성 저해 효과를 갖는 신규 펩타이드 및 그의 용도
WO2014030950A1 (ko) * 2012-08-24 2014-02-27 경상대학교 산학협력단 콜라게나제의 활성 저해 효과를 갖는 굴 가수분해물 유래 신규 펩타이드 및 그의 용도
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
FR3001889B1 (fr) 2013-02-11 2021-02-12 Expanscience Lab Utilisation d'une composition comprenant un perseose d'avocat dans la protection des cellules souches epidermiques .
WO2014165484A2 (en) * 2013-04-02 2014-10-09 Air Products And Chemicals, Inc. Compositions of delivery systems and lupine with physical stability
FR3011008B1 (fr) 2013-09-24 2017-12-29 Expanscience Lab Procedes d'evaluation des effets deleteres des uv sur la peau d'enfant
JP6209438B2 (ja) * 2013-12-19 2017-10-04 花王株式会社 水中油型乳化組成物
FR3023164B1 (fr) * 2014-07-03 2017-10-20 Expanscience Lab Extraits peptidiques de lupin et fermete de la peau
WO2016051000A1 (es) * 2014-09-29 2016-04-07 Consejo Superior De Investigaciones Científicas (Csic) Péptido aislado en un hidrolizado de altramuz y su uso en el tratamiento de enfermedades inflamatorias
GB2533379A (en) 2014-12-18 2016-06-22 Ipco 2012 Ltd A system and server for receiving transaction requests
WO2020192865A1 (en) * 2019-03-22 2020-10-01 Symrise Ag Plant peptides and their applications
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
DE102020104279A1 (de) 2020-02-18 2021-08-19 Gelita Ag Kollagenhydrolysat als Wirkstoff gegen Parodontitis oder Gingivitis
JP7569630B2 (ja) * 2020-05-25 2024-10-18 株式会社 資生堂 化粧料

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2051017A (en) * 1932-07-09 1936-08-11 Schwarz Process for producing from plant materials protein decomposition products, mineral salts, and soluble carbohydrates
US2615905A (en) * 1949-10-31 1952-10-28 Forstmann Walther Geo Heinrich Recovering valuable components from oil bearing seeds, and products therefrom
DE3219245A1 (de) 1982-05-21 1983-11-24 Mittex Ag Duengemittel aus lupinen, verfahren zu dessen herstellung und vorrichtung zur durchfuehrung des verfahrens
US4402874A (en) * 1983-01-10 1983-09-06 Thiokol Corporation Process for the preparation of protein isolates of improved quality from vegetable protein sources using alkali metal borohydrides
JP3415198B2 (ja) * 1993-06-30 2003-06-09 三省製薬株式会社 皮膚外用剤
FR2725130B1 (fr) * 1994-09-29 1996-10-31 Oreal Compositions cosmetiques contenant un compose lipidique de type ceramide et un peptide a une chaine grasse, et leurs utilisations
ATE192283T1 (de) * 1995-10-05 2000-05-15 Finanzconsul Ag Verfahren zur verarbeitung proteinhaltiger pflanzen
FR2739860B1 (fr) * 1995-10-17 1998-01-02 Coletica Complexes amphiphiles, procede pour leur preparation et compositions en renfermant
JPH107518A (ja) 1996-06-25 1998-01-13 Ikeda Bussan Kk 皮膚外用剤
FR2762512B1 (fr) 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
CN1235559C (zh) * 1998-03-11 2006-01-11 株式会社创研 皮肤水分保持能力的改善剂
FR2778565B1 (fr) * 1998-05-14 2000-07-28 Silab Sa Procede d'extraction de principes actifs vegetaux a partir de graines de lupin blanc doux, extrait obtenu et composition utilisant au moins une fraction de cet extrait
US6630163B1 (en) * 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts

Also Published As

Publication number Publication date
FR2792202B1 (fr) 2003-06-13
US20040101580A1 (en) 2004-05-27
DE60015112T2 (de) 2006-02-02
US7638149B2 (en) 2009-12-29
US20050148498A1 (en) 2005-07-07
KR20020030263A (ko) 2002-04-24
KR100818010B1 (ko) 2009-01-28
ATE279934T1 (de) 2004-11-15
FR2792202A1 (fr) 2000-10-20
EP1171143B1 (fr) 2004-10-20
DE60015112D1 (de) 2004-11-25
WO2000062789A1 (fr) 2000-10-26
JP5329731B2 (ja) 2013-10-30
US7029713B2 (en) 2006-04-18
JP2002542199A (ja) 2002-12-10
EP1171143B9 (fr) 2005-03-16
ES2228500T3 (es) 2005-04-16
DE60015112T8 (de) 2006-08-24
EP1171143A1 (fr) 2002-01-16

Similar Documents

Publication Publication Date Title
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
NZ534919A (en) Bioactive keratin peptides
FI964681A (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
AP9801392A0 (en) Concentrated antibody preparation.
CA2395266A1 (en) Use of acid-stable subtilisin proteases in animal feed
WO2001062223A3 (de) Kosmetische zubereitungen enthaltend pflanzenextrakte
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
DK1330258T3 (da) Kahalalid F-formulering
AU4411101A (en) Cosmetic preparations containing waltheria indica extracts
AU2001265885A1 (en) Cosmetic and/or pharmaceutical preparations that contain an extract of the plant argania spinosa
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
DK1146886T3 (da) Sojaekstrakt indeholdende lipider, fremgangsmåde til fremstilling heraf og farmaceutisk og kosmetisk sammensætning
EP1276757A4 (en) VAPA PROTEIN ANTIGEN PEPTIDE FRAGMENTS AND USES THEREOF
AU2002326070A1 (en) Peyers's patch and/or m-celle targeting ligands
ATE402158T1 (de) Flavonoid-derivat
AU2001252917A1 (en) 7 human ovarian and ovarian cancer associated proteins
SE0001916D0 (sv) Novel formulation
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
AU3755999A (en) Proteins that direct the secretion of virulence proteins and vaccines comprisingthem
WO2001074320A3 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
WO2001051512A3 (en) Human and parasite orphan receptor proteins
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof